Results 231 to 240 of about 379,925 (396)

Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi‐Center Retrospective Cohort

Head &Neck, EarlyView.
ABSTRACT Background Brain metastases (BM) of differentiated thyroid carcinoma (DTC) are associated with unfavorable prognosis. This study evaluated BM management strategies and patients' outcomes. Methods A retrospective review of patients diagnosed with DTC and BM at Tel Aviv Sourasky and Rabin Medical Centers between 1985 and 2024. Clinical features,
Liyona Kampel, Shaun Edalati, Eyal Yosefof, Anton Warshavsky, Gilad Horowitz, Nidal Muhanna, Hagit Shoffel‐Havakuk, Eyal Robenshtok, Aron Popovtzer, Inbar Finkel   +9 more
wiley   +1 more source

Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023. [PDF]

Eur Thyroid J
Huang NS, Chen JY, Wei WJ, Hu JQ, Wang YJ, Liu WL, Guan Q, Sun TQ, Wang YL, Xiang J, Ji QH, Ji DM, Wang Y.   +12 more
europepmc   +1 more source

Risk factors for postoperative recurrence of differentiated thyroid cancer: a retrospective study. [PDF]

Sci Rep
Han S, Yang Y, Yimaer W, Abudureheman D, Wang H.   +4 more
europepmc   +1 more source

Supplementary Table S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E Mutated Differentiated thyroid Cancer

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Ludovic Lacroix, Danielle Benisvy, David Taïeb, Stéphane Bardet, Marie Terroir-Cassou-Mounat, Nadège Anizan, Emilie Bouvier-Morel, Livia Lamartina, Georges Lion, Sarah Bétrian, Christophe Sajous, Aurélie Schiazza, Marie-Eve Garcia, Renaud Ciappuccini, Martin Schlumberger, Abir Al Ghuzlan, Yann Godbert, Isabelle Borget   +22 more
openalex   +1 more source

Histopathological, Immunohistochemical, Molecular and Genetic Biomarkers in Differentiated Thyroid Cancer. [PDF]

Cancers (Basel)
Al-Abbadi MA, Aburizeg D, Abuawad H, Alzaghloul H, Sqour O, Azab B, Qudisat T, Alabbadi AM, Mismar A, Juweid ME.   +9 more
europepmc   +1 more source

Outpatient Thyroid Remnant Ablation Using Repeated Low 131-Iodine Activities (740 MBq/20 mCi × 2) in Patients with Low-Risk Differentiated Thyroid Cancer [PDF]

, 2012
Jérôme Clerc, M. Bienvenu-Perrard, Caroline Pichard de Malleray, Françoise Dagousset, Thierry Delbot, M. L. Dreyfuss, Lionel Groussin, Robert J. Marlowe, F.A. Leger, Alain Chevalier   +9 more
openalex   +1 more source

Supplementary Data from Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial

, 2023
Marcia S. Brose, Martin Schlumbeger, Michael Jeffers, Christian Kappeler, Gerold Meinhardt, Carol E. Peña   +5 more
openalex   +1 more source

Potential neuroprotective and therapeutic agents and their mechanisms for irradiation‐induced brain injury

Ibrain, EarlyView.
In this review, agents such baicalein, troxerutin, epigallocatechin gallate, quercetin, melatonin, valproic acid, lithium, neurosteroid progesterone, as well as minocycline have been implicated as neuroprotective agents for irradiation‐induced neurological deficits. Also, agents such as glucocorticoids, methylphenidate, vitamin E, bisdemethoxycurcumin,
Seidu A. Richard, Vivian Kapio Abem, Sagor Kumar Roy   +2 more
wiley   +1 more source

Administration of multikinase inhibitor followed by radioiodine therapy for poorly differentiated thyroid cancer: a case description and systematic review. [PDF]

Quant Imaging Med Surg
Long Y, Mi YX, Li N, Li C, Ji K, Zhang W.   +5 more
europepmc   +1 more source

Crucial Role of Iodine 131 in the Management of Bone Metastasis of Differentiated Thyroid Cancer

, 2023
S.E. Bouyoucef, F Bartoli, Dalila Mouas, A. Amimour, Skander Rahabi, Amel Khelifa   +5 more
openalex   +1 more source